ULTRAGREEN AI USD ULG

USD 0.37 +4.05% +0.02 Updated 17 Nov 2026, 15:46 SGT

Company profile

The business, the people and the ownership behind ULTRAGREEN AI USD.

Business overview

About the company

UltraGreen.ai develops fluorescence-guided surgery and imaging solutions. Its products include indocyanine green imaging agents marketed as IC-GREEN and Verdye, alongside development of imaging systems and related technologies.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-09. PDF p. 5

Listed security

Company & listing

Full Company Name
ULTRAGREEN.AI LIMITED
Trading Currency
USD
Website
ultragreen.ai
Listing
Listed on 3 December 2025 on MAINBOARD
ISIN Code
SGXE24586385

Board & management

Leadership

Six Board directors: one executive CEO/director, one non-independent non-executive chairman and four independent non-executive directors, as at28February2026. The six other management members and company secretary are not additional Board directors.

All six Board biographies print appointment11November2025. The corporate roster is separately dated31December2025. Management regional titles and the joint COO/Managing Director responsibilities are preserved.

Kwa Chong Seng

Non-Independent Non-Executive Chairman

Board at 28 February 2026; appointed11November2025. Board Chairman, not Group CEO. As reported at 2026-02-28

Ravinder Sajwan

Chief Executive Officer; Executive Director

One current Group CEO and Executive Director, also described in management biography; not two people. Board appointed11November2025. As reported at 2026-02-28

Hsieh Fu Hua

Independent Non-Executive Director; Lead Independent Director

Board at28February2026; Remuneration Committee chairman. As reported at 2026-02-28

Sir David Lane

Independent Non-Executive Director

Professor Sir David Lane in the biography; same person as Sir David Lane in the31December2025 corporate roster. As reported at 2026-02-28

Nicky Tan

Independent Non-Executive Director

Audit and Nominating Committees chairman; also named Tan Ng Kuang in the dated director-interest disclosure. As reported at 2026-02-28

Toh Han Chong

Independent Non-Executive Director

Professor Toh Han Chong; current Group Board director, distinct from other external medical appointments. As reported at 2026-02-28

Declan Cassells

Chief Operating Officer; Managing Director

Managing Director (Europe and Rest of the World); executive management, not an additional Group Board seat.

Eamon Lynch

Chief Financial Officer

Current Group CFO.

Michael Broome

Chief Commercial Officer

Americas.

Fidelma Callanan

Chief Commercial Officer

Ex-Americas; distinct regional commercial executive from Michael Broome.

Quek Mei Ling

Chief Business Officer

Asia Pacific.

Theo Vouniseas

Chief Technology Officer

Current Group technology and software executive.

Lee Bee Fong

Company Secretary

ACIS; corporate information roster at31December2025.

Roles listed in ANNUAL REPORT 2025; current appointments are not independently verified.

Holdings

Ownership

Twenty registered/depository shareholders, twenty-six substantial holders and eight ownership contexts. Substantial interest columns not printed remain explicitly not printed, distinct from original zero/dash.

The repeated RGPL, AnchorVI and VerdeTaano corporate/fund/trust chains represent overlapping share blocks. Mrs Indu Rawat and Mr Mahipal Singh Rawat are expressly not Controlling Shareholders despite their beneficiary-derived deemed interests.

Share registers at18March2026, public float22.09% at24March2026. Top20 original aggregate99.09% equals the sum of individually rounded percentages; the exact aggregate share count divided by1,103,118,300 rounds to99.08%. Both original precision and the rounding distinction are retained.

Renew Group Private Limited

Direct 683,073,042 shares; 61.92%; deemed interest not printed

At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Anchor VI Pte. Ltd.

Direct 90,294,205 shares; 8.19%; deemed interest not printed

At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Verde Taano Pte. Ltd.

Direct 76,837,111 shares; 6.97%; deemed interest not printed

At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

IR Investments LP

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

IR Holding Company Inc.

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Saul Holdings Pte. Ltd.

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Saul Strategic Limited

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Mr Ravinder Sajwan

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Mrs Indu Rawat

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. Source expressly states these beneficiaries are not Controlling Shareholders, notwithstanding their deemed interests; they cannot dominate Company financial/operating policies. As reported at 2026-03-18

Mr Mahipal Singh Rawat

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. Source expressly states these beneficiaries are not Controlling Shareholders, notwithstanding their deemed interests; they cannot dominate Company financial/operating policies. As reported at 2026-03-18

Mr Low Weng Peng

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Mr Arvind Khattar

61.92%Total interest

Direct interest not printeddeemed 683,073,042 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Anchor @ 65 Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Anchor GP Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

65EP Investment IV Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

65EP Investments Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

65 Equity Partners Group Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

65 Equity Partners Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Thomson Capital Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Tembusu Capital Pte. Ltd.

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Temasek Holdings (Private) Limited

8.19%Total interest

Direct interest not printeddeemed 90,294,205 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Taano Pte. Ltd.

6.97%Total interest

Direct interest not printeddeemed 76,837,111 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

VIP V Luxembourg Manager S.à r.l.

6.97%Total interest

Direct interest not printeddeemed 76,837,111 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Vitruvian Luxcar GP S.à r.l.

6.97%Total interest

Direct interest not printeddeemed 76,837,111 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Vitruvian Partners Limited

6.97%Total interest

Direct interest not printeddeemed 76,837,111 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Vitruvian Partners LLP

6.97%Total interest

Direct interest not printeddeemed 76,837,111 shares
At18March2026. Repeated trust/fund-chain deemed interests are overlapping shares, not additive. Three direct blocks: RGPL683,073,042; AnchorVI90,294,205; VerdeTaano76,837,111. Blank opposite interest columns are not replaced by dash or zero. As reported at 2026-03-18

Number of Issued Shares

1,103,118,300

Exact ordinary-share denominator. As reported at 2026-03-18

Number of Treasury Shares Held

Nil

Printed Nil; not a missing disclosure. As reported at 2026-03-18

Number of Subsidiary Holdings Held

Nil

Printed Nil; legally defined subsidiary holdings of Company shares, not absence of operating subsidiaries. As reported at 2026-03-18

Class of Shares

Ordinary

Original share class. As reported at 2026-03-18

Voting Rights

One vote of each ordinary shares held

Original printed wording retained. As reported at 2026-03-18

DISTRIBUTION OF SHAREHOLDERS

1,346 shareholders; 1,103,118,300 shares

Original distribution aggregate. As reported at 2026-03-18

TWENTY LARGEST SHAREHOLDERS

99.09%Total interest

1,092,997,761 shares
Printed aggregate of registered/depository accounts, not beneficial free float. Printed99.09% is the sum of individually rounded percentages; exact aggregate count/issued shares rounds to99.08%. As reported at 2026-03-18

SHAREHOLDINGS IN THE HANDS OF PUBLIC

22.09%

Approximate public float as of24March2026, distinct from18March2026 registered/substantial-holder census and from shares outside top20 nominee accounts. As reported at 2026-03-24

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-18 · PDF p. 124

Registered holderInterestShares / unitsSource
RENEW GROUP PRIVATE LIMITED683,073,042 shares; 61.92%PDF p. 1242026-03-18
RAFFLES NOMINEES (PTE.) LIMITED107,121,611 shares; 9.71%PDF p. 1242026-03-18
ANCHOR VI PTE. LTD.90,294,205 shares; 8.19%PDF p. 1242026-03-18
HSBC (SINGAPORE) NOMINEES PTE LTD65,027,861 shares; 5.89%PDF p. 1242026-03-18
BPSS NOMINEES SINGAPORE (PTE.) LTD.39,040,247 shares; 3.54%PDF p. 1242026-03-18
CITIBANK NOMINEES SINGAPORE PTE LTD37,098,690 shares; 3.36%PDF p. 1242026-03-18
DBS NOMINEES (PRIVATE) LIMITED33,527,765 shares; 3.04%PDF p. 1242026-03-18
DBS VICKERS SECURITIES (SINGAPORE) PTE LTD6,683,810 shares; 0.61%PDF p. 1242026-03-18
DBSN SERVICES PTE. LTD.6,580,973 shares; 0.60%PDF p. 1242026-03-18
DB NOMINEES (SINGAPORE) PTE LTD5,705,100 shares; 0.52%PDF p. 1242026-03-18
KWA CHONG SENG5,382,832 shares; 0.49%PDF p. 1242026-03-18
MORGAN STANLEY ASIA (SINGAPORE) SECURITIES PTE LTD3,538,380 shares; 0.32%PDF p. 1242026-03-18
MAYBANK SECURITIES PTE. LTD.3,510,600 shares; 0.32%PDF p. 1242026-03-18
PHILLIP SECURITIES PTE LTD1,660,522 shares; 0.15%PDF p. 1242026-03-18
OCBC SECURITIES PRIVATE LIMITED1,232,461 shares; 0.11%PDF p. 1242026-03-18
IFAST FINANCIAL PTE. LTD.981,367 shares; 0.09%PDF p. 1242026-03-18
CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD.764,000 shares; 0.07%PDF p. 1242026-03-18
MOOMOO FINANCIAL SINGAPORE PTE. LTD.744,495 shares; 0.07%PDF p. 1242026-03-18
UOB KAY HIAN PRIVATE LIMITED534,700 shares; 0.05%PDF p. 1242026-03-18
ABN AMRO CLEARING BANK N.V.495,100 shares; 0.04%PDF p. 1242026-03-18

Group structure

Subsidiaries and associates

Fourteen subsidiary source rows contain eleven current wholly-owned subsidiaries and three former UltraLinQ entities disposedAugust2025. PerfusionTech moved from27.4%associate to100%subsidiaryJune2025; do not double-count it as a current associate.

One current associateFerronova, Australia26.9%versus24.6%. Two parent companies are explicitly identified above the Group and are not operating subsidiaries.

Renew Pharmaceuticals Limited and HUB Pharmaceuticals, LLC are named principal subsidiaries. New UltraGreen Data Systems entities are distinct from sold Ultralinq legal entities. Source ownership is Group effective interest, not substituted parent direct stakes.

CompanyMarketOwnership interest
UltraGreen DACGroup effective equity interest at31December2025 and31December2024. Held by Company.PDF p. 962025-12-31 Ireland; current 100%; comparative 100%
Ultralinq Healthcare Solutions LimitedGroup effective equity interest at31December2025 and31December2024. Held by UltraGreen DAC. Entire UltraLinQ segment disposed August2025, with loss of control; current interest dash, prior100%. Not a current subsidiary.PDF p. 962025-12-31 United Kingdom; current –; comparative 100%
Ultralinq Healthcare Solutions Inc.Group effective equity interest at31December2025 and31December2024. Held by UltraGreen DAC. Entire UltraLinQ segment disposed August2025, with loss of control; current interest dash, prior100%. Not a current subsidiary.PDF p. 962025-12-31 United States; current –; comparative 100%
Renew Pharmaceuticals LimitedGroup effective equity interest at31December2025 and31December2024. Held by UltraGreen DAC. Explicitly identified as a principal subsidiary; consolidated Group financial statements audited by KPMG LLP.PDF p. 962025-12-31 Ireland; current 100%; comparative 100%
Ultralinq Merger Sub, Inc.Group effective equity interest at31December2025 and31December2024. Held by Ultralinq Healthcare Solutions Inc.. Entire UltraLinQ segment disposed August2025, with loss of control; current interest dash, prior100%. Not a current subsidiary.PDF p. 962025-12-31 United States; current –; comparative 100%
Diagnostic Green GmbHGroup effective equity interest at31December2025 and31December2024. Held by Renew Pharmaceuticals Limited.PDF p. 962025-12-31 Germany; current 100%; comparative 100%
Diagnostic Green LimitedGroup effective equity interest at31December2025 and31December2024. Held by Renew Pharmaceuticals Limited.PDF p. 962025-12-31 Ireland; current 100%; comparative 100%
Renew Holdings, Inc.Group effective equity interest at31December2025 and31December2024. Held by Renew Pharmaceuticals Limited.PDF p. 962025-12-31 United States; current 100%; comparative 100%
Perfusion Tech ApSGroup effective equity interest at31December2025 and31December2024. Held by Renew Pharmaceuticals Limited. Former associate27.4%; remaining interest acquired June2025 and current subsidiary100%. Not counted as a second current associate merely because Note9 also lists the transition.PDF p. 962025-12-31 Denmark; current 100%; comparative 27.4%
UltraGreen Data Systems LimitedGroup effective equity interest at31December2025 and31December2024. Held by Renew Pharmaceuticals Limited. Established in2025 after UltraLinQ disposal; distinct from sold Ultralinq entities.PDF p. 962025-12-31 United Kingdom; current 100%; comparative –
Renew Hub LLCGroup effective equity interest at31December2025 and31December2024. Held by Renew Holdings, Inc..PDF p. 972025-12-31 United States; current 100%; comparative 100%
Diagnostic Green LLCGroup effective equity interest at31December2025 and31December2024. Held by Renew Holdings, Inc..PDF p. 972025-12-31 United States; current 100%; comparative 100%
UltraGreen Data Systems Inc.Group effective equity interest at31December2025 and31December2024. Held by Renew Holdings, Inc.. Established in2025 after UltraLinQ disposal; distinct from sold Ultralinq entities.PDF p. 972025-12-31 United States; current 100%; comparative –
HUB Pharmaceuticals, LLCGroup effective equity interest at31December2025 and31December2024. Held by Renew Hub LLC. Explicitly identified as a principal subsidiary; consolidated Group financial statements audited by KPMG LLP.PDF p. 972025-12-31 United States; current 100%; comparative 100%
Renew Group Private LimitedHolding company above UltraGreen.ai, not an operating subsidiary of the Group. Relationship separately described from subsidiary and associate stakes.PDF p. 73 Singapore; immediate holding company
Saul Strategic LimitedHolding company above UltraGreen.ai, not an operating subsidiary of the Group. Relationship separately described from subsidiary and associate stakes.PDF p. 73 Singapore; ultimate holding company
Ferronova Pty LtdOne current equity-accounted associate. Perfusion Tech is now a subsidiary after June2025; not a second current associate. Financial summaries disclose full investee amounts separately from Group share.PDF p. 972025-12-31 Australia; current26.9%; comparative24.6%

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
Ravinder Sajwan Chief Executive Officer and Executive Director Management Team PDF p. 15
Declan Cassells Chief Operating Officer and Managing Director (Europe and Rest of the World) Group Management PDF p. 127
Eamon Lynch Chief Financial Officer Group Management PDF p. 127
Michael Broome Chief Commercial Officer (Americas) Group Management PDF p. 127
Fidelma Callanan Chief Commercial Officer (Ex-Americas) Group Management PDF p. 127
Quek Mei Ling Chief Business Officer (Asia Pacific) Group Management PDF p. 127
Theo Vouniseas Chief Technology Officer Group Management PDF p. 127

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Number of Issued Shares 1,103,118,300 shares Company · As at 2026-03-18 PDF p. 124
Class of Shares Ordinary Company · As at 2026-03-18 PDF p. 124
Voting Rights One vote of each ordinary shares held Company · As at 2026-03-18 PDF p. 124

Treasury shares

ItemValuePeriod / scopeSource
Number of Treasury Shares Held Nil Company · As at 2026-03-18 PDF p. 124
Number of Subsidiary Holdings(1) Held Nil Company · As at 2026-03-18 PDF p. 124

Shareholding distribution

ItemValuePeriod / scopeSource
100 – 1,000 364 shareholders; 27.04% of shareholders; 328,139 shares; 0.03% of shares Size band · As at 2026-03-18 PDF p. 124
1,001 – 10,000 804 shareholders; 59.73% of shareholders; 4,122,100 shares; 0.38% of shares Size band · As at 2026-03-18 PDF p. 124
10,001 – 1,000,000 163 shareholders; 12.11% of shareholders; 9,189,962 shares; 0.83% of shares Size band · As at 2026-03-18 PDF p. 124
1,000,001 AND ABOVE 15 shareholders; 1.12% of shareholders; 1,089,478,099 shares; 98.76% of shares Size band · As at 2026-03-18 PDF p. 124
TOTAL 1,346 shareholders; 100.00% of shareholders; 1,103,118,300 shares; 100.00% of shares All shareholders · As at 2026-03-18 PDF p. 124

Free float

ItemValuePeriod / scopeSource
Shareholdings in the hands of public approximately 22.09% Company · As at 2026-03-24 PDF p. 125
Shareholdings in the hands of public the Company has complied with Rule 723 of the Listing Manual Company · As at 2026-03-24 PDF p. 125

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
RGPL 144,369(1) US$'000 Aggregate value of all interested person transactions during FY2025 (excluding <S$100,000 and Rule 920 mandate) PDF p. 49
LifeSignals Inc. 158(2) US$'000 Aggregate value of all interested person transactions during FY2025 (excluding <S$100,000 and Rule 920 mandate) PDF p. 49
Renew Health (UK) Limited 296(3) US$'000 Aggregate value of all interested person transactions during FY2025 (excluding <S$100,000 and Rule 920 mandate) PDF p. 49
Renew Health Limited 7,143(4) US$'000 Aggregate value of all interested person transactions during FY2025 (excluding <S$100,000 and Rule 920 mandate) PDF p. 49
ETPL Quant Limited 1,110(5) US$'000 Aggregate value of all interested person transactions during FY2025 (excluding <S$100,000 and Rule 920 mandate) PDF p. 49
5-Hour International Corporation Private Limited 220(6) US$'000 Aggregate value of all interested person transactions during FY2025 (excluding <S$100,000 and Rule 920 mandate) PDF p. 49

Director remuneration

ItemValuePeriod / scopeSource
Mr Kwa Chong Seng 45 S$'000 FY2025 total remuneration, Non-Executive Chairman PDF p. 47
Mr Hsieh Fu Hua 21 S$'000 FY2025 total remuneration, Independent Non-Executive Director and Lead Independent Director PDF p. 47
Professor Sir David Lane 13 S$'000 FY2025 total remuneration, Independent Non-Executive Director PDF p. 47
Mr Nicky Tan 18 S$'000 FY2025 total remuneration, Independent Non-Executive Director PDF p. 47
Professor Toh Han Chong 10 S$'000 FY2025 total remuneration, Independent Non-Executive Director PDF p. 47
Mr Ravinder Sajwan – S$'000 FY2025 total remuneration, Chief Executive Officer and Executive Director PDF p. 47
aggregate total remuneration paid to these key management personnel S$3,606,415 (equivalent to US$2,741,319) Top six key management personnel (not directors or CEO), FY2025 PDF p. 47

Employees

ItemValuePeriod / scopeSource
Permanent Employees 101 count Group, permanent employees across Singapore and Ireland PDF p. 28

Outlook

ItemValuePeriod / scopeSource
FY2026 Outlook: Confidence in Continued Growth range of US$170 - US$190 million FY2026 revenue forecast, Chairman & CEO's statement PDF p. 19
Chairman & CEO closing statement The best is ahead. Chairman & CEO's statement PDF p. 19

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Source: ANNUAL REPORT 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
09 Sep 2024
Email
[email protected]
Telephone
65 98172903
Registered Office
463 MACPHERSON ROAD
#06-00, M463
Singapore 368181
Secretary
Lee Bee Fong
Registrar / Transfer Agent
BOARDROOM CORPORATE & ADVISORY SERVICES PTE. LTD.
Registrar Address
1 Harbourfront Avenue, Keppel Bay Tower, #14-07, Singapore 098632
Auditors
KPMG LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE LTD.
Country
SINGAPORE
Security Type
stocks